Joel Schneider
Vorstandsvorsitzender bei Carbon Biosciences, Inc.
Aktive Positionen von Joel Schneider
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Carbon Biosciences, Inc.
Carbon Biosciences, Inc. Medical/Nursing ServicesHealth Services Carbon Biosciences, Inc. is a biotech company that is based in Boston, MA. The company is focused on expanding the therapeutic potential of gene therapy through its proprietary platform which leverages novel parvoviruses that have been pressure tested by nature to target specific tissues and carry a larger cargo with minimal neutralizing immunity and the potential to re-dose. The company is working to expand the gene therapy toolbox for the treatment of the world's most devastating and difficult to treat diseases. Carbon was founded by Longwood Fund and gene therapy pioneers, John F. Engelhardt, Ph.D., and Robert M. Kotin, Ph.D. | Vorstandsvorsitzender | - | - |
Präsident | - | - |
Karriereverlauf von Joel Schneider
Ehemalige bekannte Positionen von Joel Schneider
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SOLID BIOSCIENCES INC. | Direktor/Vorstandsmitglied | 01.03.2015 | 01.01.2017 |
Geschäftsführer | 02.03.2021 | 27.05.2022 | |
Technik-/Wissenschafts-/F&E-Leiter | 01.01.2017 | 02.03.2021 | |
Corporate Officer/Principal | 01.03.2014 | 01.03.2015 |
Ausbildung von Joel Schneider
Brandeis University | Undergraduate Degree |
Rutgers State University of New Jersey | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Frankreich | 2 |
Operativ
Director/Board Member | 1 |
Chief Operating Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 2 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SOLID BIOSCIENCES INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Carbon Biosciences, Inc.
Carbon Biosciences, Inc. Medical/Nursing ServicesHealth Services Carbon Biosciences, Inc. is a biotech company that is based in Boston, MA. The company is focused on expanding the therapeutic potential of gene therapy through its proprietary platform which leverages novel parvoviruses that have been pressure tested by nature to target specific tissues and carry a larger cargo with minimal neutralizing immunity and the potential to re-dose. The company is working to expand the gene therapy toolbox for the treatment of the world's most devastating and difficult to treat diseases. Carbon was founded by Longwood Fund and gene therapy pioneers, John F. Engelhardt, Ph.D., and Robert M. Kotin, Ph.D. | Health Services |
- Börse
- Insiders
- Joel Schneider
- Erfahrung